Estimating Stage 4 Chronic Kidney Disease Cases Using Laboratory Records in France
Checks whether lab records can estimate advanced kidney disease in adults in one French region.
Plain-language title generated from the registry record
Registry title: Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France
Key facts
- Where
- Alès and Nîmes, FranceSee the 4 sites
Where in France
- AIDER - Unité de Dialyse d'AlèsAlès, FranceTaking people
- AIDER - Unité de Dialyse de Nîmes, CHU CarémeauNîmes, FranceNot yet recruiting
- CHU de Nimes - Hopital Universitaire CaremeauNîmes, FranceNot yet recruiting
- GardialyseNîmes, FranceNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre Hospitalier Universitaire de Nīmes
- Trial code
- NCT02938611
- Record updated
- 20 October 2026
- Original description
The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.Read full original descriptionShow less
Feasibility Study on Estimating the Prevalence and Management of Stage 4 Chronic Kidney Disease in Adults Via Laboratories and Nephrologists in the Gard, France
The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.
Inclusion: chronic kidney disease (stage >= 4).
Exclusion: -.